Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Chiara Sergi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancers|March 11, 2023
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal TherapiesValeria Internò, Maria Chiara Sergi, Maria Elvira Metta, et al.
International Journal of Molecular Sciences|August 6, 2020
Non-Melanoma Skin Cancers: Biological and Clinical FeaturesMauro Cives, Francesco Mannavola, Lucia Lospalluti, et al.
Frontiers in Immunology|May 4, 2026
Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world studyFrancesco Caraglia, Giuseppe Argenziano, Marcella Scala, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2024
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international studyMario Mandalà, Paul Lorigan, Maria Chiara Sergi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2025
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective studyMario Mandalà, Teresa Amaral, Piotr Rutkowski, et al.
Journal of Translational Medicine|June 25, 2021
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohortDaniele Santini, Tea Zeppola, Marco Russano, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastasesMario Mandalà, Monica F Chen, Ryan J Sullivan, et al.
Journal of the National Cancer Institute|April 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort studyLuca Cantini, Francesco Paoloni, Federica Pecci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with CancerAlessio Cortellini, Antonio D'Alessio, Siobhan Cleary, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancers|March 11, 2023
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal TherapiesValeria Internò, Maria Chiara Sergi, Maria Elvira Metta, et al.
International Journal of Molecular Sciences|August 6, 2020
Non-Melanoma Skin Cancers: Biological and Clinical FeaturesMauro Cives, Francesco Mannavola, Lucia Lospalluti, et al.
Frontiers in Immunology|May 4, 2026
Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world studyFrancesco Caraglia, Giuseppe Argenziano, Marcella Scala, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2024
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international studyMario Mandalà, Paul Lorigan, Maria Chiara Sergi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2025
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective studyMario Mandalà, Teresa Amaral, Piotr Rutkowski, et al.
Journal of Translational Medicine|June 25, 2021
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohortDaniele Santini, Tea Zeppola, Marco Russano, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastasesMario Mandalà, Monica F Chen, Ryan J Sullivan, et al.
Journal of the National Cancer Institute|April 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort studyLuca Cantini, Francesco Paoloni, Federica Pecci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with CancerAlessio Cortellini, Antonio D'Alessio, Siobhan Cleary, et al.
Pageof 2